Mehdi Khaled

3.6k citations
29 papers · 2.4k indexed · 1 hit paper · h-index 19

Mehdi Khaled

28 papers receiving 2.3k citations

Hit Papers

MITF: master regulator of melanocyte development and mela...8732006202620122019250500750

Peers

Mehdi Khaled
Comparison fields: 5 of 97
  • Cell Biology 1.2k
  • Dermatology 349
  • Cancer Research 535
  • Sensory Systems 161
  • Nutrition and Dietetics 479
Replace Karine Bille with:
Karine Bille France
Patricia Abbe France
Timothy J. Hemesath United States
Marjan Askarian-Amiri New Zealand
Neil F. Box United States
Arlo J. Miller United States
Laurence Denat France
Hidenori Watabe Japan
J Vachtenheim Czechia
Sreenivasulu Chintala United States
Mehdi Khaled relative to Karine Bille France Karine Bille's profile →
Citations per field
00.5×1.5×2.3×
Karine Bille · 1×
Citations per year

Countries citing papers authored by Mehdi Khaled

Since Specialization
Citations

This map shows the geographic impact of Mehdi Khaled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Khaled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Khaled more than expected).

Fields of papers citing papers by Mehdi Khaled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehdi Khaled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Khaled. The network helps show where Mehdi Khaled may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mehdi Khaled, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mehdi Khaled Line = papers co-authored together Mehdi Khaled links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20240
3 201923
4 20186
5 201731
6 201715
7 201630
8 201566
9 201390
10 201169
11 201197
12 2010218
13 201099
14 201056
15 200961
16
MITF: master regulator of melanocyte development and melanoma oncogenebreakdown →
2006873
17 200557
18 200380
19 2002147
20
Role, Significance and Association of microRNA-10a/b in Physiology of Cancer
19692

About Mehdi Khaled

Mehdi Khaled is a scholar working on Cell Biology, Cancer Research and Immunology, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include melanin and skin pigmentation (13 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), RNA regulation and disease (4 papers), CRISPR and Genetic Engineering (4 papers), Mast cells and histamine (4 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cell Biology (1.2k citations), Dermatology (349 citations) and Cancer Research (535 citations). Mehdi Khaled has collaborated with scholars based in France, United States and Israel. Frequent co-authors include Carmit Levy, David E. Fisher, Robert Ballotti, Corine Bertolotto, Karine Bille, Lionel Larribère, Satoru Yokoyama, Steffen Schubert, Maja M. Janas and Jun S. Song.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026